Showing results (211-220 of 308) with videos related to

Sort By:
Pageof 31
Parkinsonism & Related Disorders|April 17, 2024
OFF-times before, during, and after nighttime sleep periods in Parkinson's disease patients with motor fluctuations and the effects of opicapone: A post hoc analysis of diary data from BIPARK-1 and -2Robert A Hauser, Aleksandar Videnovic, Patrício Soares-da-Silva, et al.
Parkinson'S Disease|May 7, 2014
Minimal clinically important difference in Parkinson's disease as assessed in pivotal trials of pramipexole extended releaseRobert A Hauser, Mark Forrest Gordon, Yoshikuni Mizuno, et al.
Brain : a Journal of Neurology|February 5, 2013
Striatal allografts in patients with Huntington's disease: impact of diminished astrocytes and vascularization on graft viabilityGiulia Cisbani, Thomas B Freeman, Denis Soulet, et al.
Parkinsonism & Related Disorders|September 24, 2013
Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's diseaseRajesh Pahwa, Kelly E Lyons, Robert A Hauser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 4, 2010
Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's diseaseJuliana Bronzova, Cristina Sampaio, Robert A Hauser, et al.
Clinical Neuropharmacology|August 2, 2008
Caffeine and progression of Parkinson diseaseDavid K Simon, Christopher J Swearingen, Robert A Hauser, et al.
Parkinsonism & Related Disorders|November 1, 2020
A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's diseaseEric S Farbman, Cheryl H Waters, Peter A LeWitt, et al.
CNS Spectrums|November 20, 2020
Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practiceRobert A Hauser, Jonathan M Meyer, Stewart A Factor, et al.
Plos One|April 14, 2021
Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b studyAtul T Patel, Mark F Lew, Khashayar Dashtipour, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 27, 2007
Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopaRobert A Hauser, Olivier Rascol, Amos D Korczyn, et al.
Pageof 31